Health ❯ Patient Care

Treatment Efficacy

Clinical Outcomes Survival Rates Adverse Reactions Clinical Studies Adverse Events Safety Profiles Side Effects Clinical Remission Quality of Life Drug Response Weight Management

Pfizer’s Monthly Obesity Shot Shows Mid-Stage Gains With Up to 12.3% Weight Loss

Pfizer plans 10 phase 3 trials this year to test higher monthly doses suggested by the phase 2 data.

Eupraxia Reports Early EoE Trial Data With Near‑Normal Tissue at Top Dose

Pluvicto Added to Standard Care Extends rPFS in PSMA-Positive Metastatic Hormone-Sensitive Prostate Cancer

FDA Approves Papzimeos as First Therapy for Adult Recurrent Respiratory Papillomatosis

Nektar Therapeutics’ Rezpegaldesleukin Trial Success Sends Shares Up 150%